IP Library Assignment 045523/0937
Patent Assignment
Reel/Frame 045523/0937

Assignment of Assignor's Interest

Recorded: 2018-04-12 Pages: 8
Assignor
SPIROGEN SÀRL
Executed: 2016-01-12
Assignee
MEDIMMUNE LIMITED
MILSTEIN BUILDING, GRANTA PARK, CAMBRIDGE, ENGLAND, CB21 6GH, UNITED KINGDOM
Covered Property (1)
Anti-DLL3 Antibody Drug Conjugates for Treating Cancer
Application: 15/946,459 →
Publication: US 2018/0318441
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 12, 2018
From: TORGOV, MICHAEL
To: STEM CENTRX, INC.
Reel/Frame 045523/0397 →
Assignment of Assignor's Interest Apr 12, 2018
From: HOWARD, PHILIP WILSON
To: SPIROGEN SÀRL
Reel/Frame 045523/0511 →
Merger Apr 12, 2018
From: STEMCENTRX, INC.
To: ABBVIE STEMCENTRX LLC
Reel/Frame 045523/0677 →
Change of Name Apr 12, 2018
From: STEM CENTRX, INC.
To: STEMCENTRX, INC.
Reel/Frame 045929/0001 →